* * Interpretation

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final SUGAR ADVANCE ANEL MICROALBUMIN,1ST MORNING/RANDOM URINE (Immunoturbidimetry,Spectrophotometry) Microalbumin 45.00 Creatinine 22.00 Microalbumin Creatinine Ratio 204.55 mg/g creatinine <30.00 Interpretation ----------------------------------------------------------- CATEGORY REFERENCE RANGE IN mg/g creatinine ---------------------- ------------------------------------ Normal/Non diabetic <30 ---------------------- ------------------------------------ Microalbuminuria 30-300 ---------------------- ------------------------------------ Clinical albuminuria > 300 ----------------------------------------------------------- Note It is recommended that at least two of three specimens collected within a 3-6 month period be abnormal before considering a patient to be within a diagnostic category. Clinical Use Early detection of Diabetic nephropathy Therapeutic monitoring of patients with Nephropathy Routine management of patients with Diabetes GLUCOSE, FASTING (F), LASMA (Hexokinase) GLUCOSE, OST RANDIAL (), 2 HOURS, LASMA (Hexokinase) 80.00 93.00 LIID SCREEN, SERUM (Spectrophotometry) Cholesterol, Total 250.00 atientreportscsuperanel.s_general_temlate01_sc (Version 7) age 1 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final Triglycerides 112.00 HDL Cholesterol 45.00 LDL Cholesterol, Calculated 182.60 VLDL Cholesterol,Calculated 22.40 Interpretation ------------------------------------------------------------- REMARKS TOTAL TRIGLYCERIDE LDL CHOLESTEROL CHOLESTEROL in mg/dl in mg/dl in mg/dl Optimal <200 <150 <100 Above Optimal - - 100-129 Borderline High 200-239 150-199 130-159 High >=240 200-499 160-189 Very High - >=500 >=190 ------------------------------------------------------------- Note 1. Measurements in the same patient can show physiological & analytical variations. Three serial samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol. 2. AT III recommends a complete lipoprotein profile as the initial test for evaluating cholesterol. 3. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400 mg/dl. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is >400 mg/dl. VITAMIN D, 25 - HYDROXY, SERUM (CLIA) 45.20 Interpretation ------------------------------------------------------------- LEVEL REFERENCE RANGE COMMENTS IN nmol/l --------------- ----------------- --------------------------- Deficient < 50 High risk for developing bone disease --------------- ----------------- --------------------------- Insufficient 50-74 Vitamin D concentration atientreportscsuperanel.s_general_temlate01_sc (Version 7) age 2 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final which normalizes arathyroid hormone concentration --------------- ----------------- --------------------------- Sufficient 75-250 Optimal concentration for maximal health benefit --------------- ----------------- --------------------------- otential >250 High risk for toxic intoxication effects ------------------------------------------------------------- Note The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D. 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function. Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/l. It shows seasonal variation, with values being 40-50% lower in winter than in summer. Levels vary with age and are increased in pregnancy. A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available Comments Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency in children causes Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and Tetany. Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs). Decreased Levels Inadequate exposure to sunlight Dietary deficiency Vitamin D malabsorption Severe Hepatocellular disease Drugs like Anticonvulsants Nephrotic syndrome Increased levels Vitamin D intoxication TSH, ULTRASENSITIVE, SERUM (CLIA) atientreportscsuperanel.s_general_temlate01_sc (Version 7) 4.500 age 3 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final Note 1. TSH levels are subject to circadian variation, reaching peak levels between 2-4.a.m. and at a minimum between 6-10 pm. The variation is of the order of 50%, hence time of the day has influence on the measured serum TSH concentrations. 2. Values <0.03 uiu/ml need to be clinically correlated due to presence of a rare TSH variant in some individuals Clinical Use Diagnose Hypothyroidism and Hyperthyroidism Monitor T4 replacement or T4 suppressive therapy Quantify TSH levels in the subnormal range Increased Levels rimary hypothyroidism, Subclinical hypothyroidism, TSH dependent Hyperthyroidism, Thyroid hormone resistance Decreased Levels Graves disease, Autonomous thyroid hormone secretion, TSH deficiency atientreportscsuperanel.s_general_temlate01_sc (Version 7) age 4 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final LIVER ANEL 1; LFT,SERUM (Spectrophotometry) Bilirubin Total Bilirubin Direct 1.20 0.50 Bilirubin Indirect 0.70 mg/dl <1.10 AST (SGOT) ALT (SGT) GGT Alkaline hosphatase (AL) Total rotein Albumin 10 15 20 45 6.30 4.20 2.00 A G Ratio 0.90-2.00 Note In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or Non alcoholic fatty liver disease, Enhanced liver fibrosis (ELF) test may be used to evaluate liver fibrosis. KIDNEY ANEL; KFT,SERUM (Spectrophotometry, Indirect ISE) Urea Creatinine Uric Acid Calcium, Total hosphorus Alkaline hosphatase (AL) Total rotein Albumin 22.00 0.80 5.30 8.50 5.60 45 6.30 4.20 2.00 A G Ratio 0.90-2.00 Sodium otassium Chloride 141.00 3.90 101.00 atientreportscsuperanel.general_anel_analyte_sc (Version 6) age 5 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final COMLETE BLOOD COUNT (CBC) (Electrical Impedance & VCS,hotometry ) Hemoglobin acked Cell Volume (CV) RBC Count MCV MCH MCHC Red Cell Distribution Width (RDW) Total Leukocyte Count (TLC) Differential Leucocyte Count (DLC) 13.50 41.20 4.61 89.40 29.30 32.70 13.70 8.56 Segmented Neutrophils 59.30 Lymphocytes 36.80 Monocytes 2.90 Eosinophils 0.90 Basophils 0.10 Absolute Leucocyte Count Neutrophils 5.08 Lymphocytes 3.15 Monocytes 0.25 Eosinophils 0.08 Basophils 0.01 latelet Count 221.0 Note 1. As per the recommendation of International council for Standardization in Hematology, the differential leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of blood 2. Test conducted on EDTA whole blood age 6 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final URINE EXAMINATION, ROUTINE; URINE, R/E (Automated Strip Test, Microscopy) hysical Colour Specific Gravity ph Chemical roteins Glucose Ketones Bilirubin Urobilinogen Leucocyte Esterase Nitrite Microscopy R.B.C. us Cells Epithelial Cells Casts Crystals Light Yellow 1.025 5.5 Normal Few ale yellow 5.0-8.0 Normal 0-5 WBC / hpf Few /lpf Others - atientreportscsuperanel.urine_examination_sc (Version 6) age 7 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD (HLC, NGS certified) 6.5 Interpretation ------------------------------------------------------------------------------- As per American Diabetes Association (ADA) ------------------------------------------------------------------------------- Reference Group HbA1c in % ------------------------------- ----------------------------------------------- Non diabetic adults >=18 years <5.7 ------------------------------- ----------------------------------------------- At risk (rediabetes) 5.7-6.4 ------------------------------- ----------------------------------------------- Diagnosing Diabetes >= 6.5 ------------------------------- ----------------------------------------------- Therapeutic goals for glycemic Age > 19 years control. Goal of therapy < 7.0. Action suggested > 8.0 Age < 19 years. Goal of therapy <7.5 ------------------------------------------------------------------------------- Note 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled. 2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate. Comments HbA1c provides an index of average blood glucose levels over the past 8-12 weeks and is a much better indicator of long term glycemic control as compared to blood and urinary glucose determinations. ADA criteria for correlation between HbA1c & Mean plasma glucose levels --------------------------------------- HbA1c(%) Mean lasma Glucose (mg/dl) 6 126 7 154 8 183 atientreportscsuperanel.hbelectro_sc (Version 7) age 8 of 9

LL - LL-ROHINI (NATIONAL REFERENCE 139242049 Age Unknown Gender Unknown 9/3/2018 120000AM 9/3/2018 40032M 10/3/2018 24647M Ref By Final 9 212 10 240 11 269 12 298 --------------------------------------- Dr. Anil Arora MD (athology) HOD Hemat & Imm - NRL Dr Biswadip Hazarika MD (athology) Sr. Consultant athologist - NRL Dr Himangshu Mazumdar MD (Biochemistry) Consultant Biochemist - NRL Dr. Nimmi Kansal MD (Biochemistry) HOD Biochem & IA - NRL Dr. Shalabh Malik MD (Microbiology) National Head - Microbiology & Serology - NRL -------------------------------End of report -------------------------------- atientreportscsuperanel.hbelectro_sc (Version 7) age 9 of 9